재택 수액 요법 시장 : 기회, 성장 촉진요인, 산업 동향 분석과 예측(2024-2032년)

Home infusion therapy market size is anticipated to record an 11% CAGR from 2024 to 2032 led by the rising prevalence of chronic diseases and an aging population. Reports indicate that approximately one in three adults grapple with multiple chronic conditions. With the increasing prevalence of diseases like diabetes, cancer, and cardiovascular issues, there is a heightened demand for continuous and tailored treatment solutions. Home infusion therapy provides a convenient and effective means for patients to receive essential medications and treatments right at home, minimizing the necessity for frequent hospital visits.

Recent advancements in infusion technology, particularly portable and user-friendly infusion pumps, have revolutionized medication management at home. Furthermore, the growing availability of specialized infusion services, coupled with professional healthcare support, bolsters the safety and feasibility of home infusion therapy.

The overall industry is divided into product, application, and region.

Based on product, the home infusion therapy market from the needleless connectors segment is expected to record a significant CAGR from 2024 to 2032 due to their ability to enhance safety and ease of use. By eliminating needles during medication administration, needleless connectors drastically lower the risk of needle-stick injuries and infections, a crucial advantage in home care settings. Their user-friendly nature ensures smoother, more hygienic medication administration, thereby enhancing patient comfort and adherence to treatment protocols.

Home infusion therapy market value from the hydration therapy application segment is projected to rise from 2024 to 2032. This is owing to its essential role in managing dehydration and supporting patients with chronic conditions or undergoing intensive treatments. Hydration therapy is increasingly being provided at home to improve patient comfort and convenience.

Asia Pacific home infusion therapy industry is projected to exhibit lucrative growth between 2024 and 2032. This surge is driven by a rising prevalence of chronic diseases, an expanding elderly demographic, and notable advancements in healthcare infrastructure. As conditions like diabetes, cancer, and cardiovascular diseases gain prominence in the region, the appetite for home-based treatment solutions intensifies.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing hospital acquired infections
    • 3.2.1.2 Rising prevalence of chronic diseases
    • 3.2.1.3 Advancements in technology
    • 3.2.1.4 Growing geriatric population
    • 3.2.1.5 Increasing preference towards at-home healthcare solutions
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Dearth of reimbursement
    • 3.2.2.2 Safety concerns and risk of failure associated with home infusion devices
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trends in home infusion therapy industry
• 3.6 Gap analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future prospects for home infusion therapy industry

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Infusion pumps
• 5.3 Intravenous sets
• 5.4 IV cannulas
• 5.5 Needleless connectors

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Anti-infective
• 6.3 Hydration therapy
• 6.4 Chemotherapy
• 6.5 Enteral nutrition
• 6.6 Parenteral nutrition
• 6.7 Specialty pharmaceuticals
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
  • 7.3.7 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
  • 7.4.6 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East and Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

• 8.1 AMERITA INC.
• 8.2 Amsino International, Inc.
• 8.3 B. Braun Melsungen AG
• 8.4 Baxter International Inc.
• 8.5 Becton Dickinson and Company
• 8.6 Contec Medical Systems Co. Ltd
• 8.7 Erenler Medikal
• 8.8 Fresenius Kabi
• 8.9 Halyard Health, Inc. (Avanos Medical)
• 8.10 ICU Medical Inc.
• 8.11 JMS Co. Ltd.
• 8.12 Lepu Medical Technology
• 8.13 Moog Inc.
• 8.14 Option Care Health, Inc.
• 8.15 Terumo Corporation